62358-68-3

Basic information

• Product Name: Phenol, 3-(bromomethyl)-5-methyl-, acetate
• CAS NO: 62358-68-3
• Molecular Formula: C10H11BrO2
• Molecular Weight: 243.1
• Mol File: 62358-68-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Phenol, 3-(bromomethyl)-5-methyl-, acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 3-(bromomethyl)-5-methyl-, acetate(62358-68-3)
• EPA Substance Registry System: Phenol, 3-(bromomethyl)-5-methyl-, acetate(62358-68-3)

Safety Data

• Hazardous Substances Data: 62358-68-3(Hazardous Substances Data)

Upstream product

• 108-68-9 3,5-Dimethylphenol 
• 877-82-7 5-acetoxy-m-xylene 

Downstream Products

• 22524-06-7 3-(3-Methoxy-5-methyl-phenyl)-propanol-⁽¹⁾ 
• 62641-08-1 Methanesulfonic acid 3-(3-methoxy-5-methyl-phenyl)-propyl ester 
• 60549-28-2 3-Hydroxy-5-methyl-dihydrozimtsaeure 
• 62358-70-7 3-(3-Hydroxy-5-methyl-phenyl)-propionic acid methyl ester 
• 62358-71-8 3-methyl-5-methoxydihydrocinnamic acid methyl ester 
• 62358-72-9 4-(3-Methoxy-5-methyl-phenyl)-butyronitrile 
• 18458-09-8 4-(3-Methoxy-5-methyl-phenyl)-butyric acid 
• 57281-57-9 3-(Acetyloxy)-5-methylbenzyl acetate 
• 1415562-82-1 (2R)-1-[[4-[[3-(benzenesulfonylmethyl)-5-methylphenoxymethyl]phenyl]methyl]pyrrolidin-2-yl]methanol 
• 1415562-82-1 (S)-[1-(4-{[3-methyl-5-(phenylsulfonylmethyl)phenoxy]methyl}benzyl)pyrrolidin-2-yl]methanol 

Relevant articles and documents

Synthesis of dansyl labeled sphingosine kinase 1 inhibitor

PF-543 is a non-sphingosine analogue with inhibitory effect against SK1, based on a Ki of 4.3 nM and 130-fold selectivity for SK1 over SK2. Since the development of PF-543, animal studies demonstrated its valuable role in multiple sclerosis, myocardial in

FURAN OR THIOPHENE DERIVATIVE AND MEDICINAL USE THEREOF

The present invention provides a compound represented by the formula (I): [wherein R is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, p is 0, 1 or 2, and when p is 2, each R may be the same or different, R1 is a hydrogen atom or an optionally substituted hydrocarbon group, R2 is an optionally substituted aromatic group, Ring A is an optionally substituted monocyclic aromatic ring or optionally substituted bicyclic aromatic fused ring, X1 is an oxygen atom or a sulfur atom, X2 is a bond, an oxygen atom or -S(O)n- (wherein n is 0, 1 or 2), Y is a bond, an oxygen atom, -S(O)m-, -C(=O)-N(R3)- or -N(R3)-C(=O)- (R3 is a hydrogen atom, an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, and m is 0, 1 or 2), M1, M2 and M3 may be the same or different and are each independently a bond or an optionally substituted divalent aliphatic hydrocarbon group, and M4 is an optionally substituted divalent aliphatic hydrocarbon group] or a salt thereof, which is useful as a prophylactic and/or therapeutic agent for lipid metabolism abnormality, arteriosclerotic disease and sequelae thereof, diabetes mellitus and the like.